Royce & Associates’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50,000
Closed -$4.36M 958
2022
Q1
$4.36M Buy
50,000
+976
+2% +$88.3K 0.04% 583
2021
Q4
$4.74M Sell
49,024
-2,900
-6% -$279K 0.04% 580
2021
Q3
$4.62M Sell
51,924
-100
-0.2% -$8.81K 0.03% 601
2021
Q2
$4.71M Buy
52,024
+3,000
+6% +$280K 0.03% 615
2021
Q1
$4.41M Buy
49,024
+8,524
+21% +$729K 0.03% 628
2020
Q4
$3.19M Buy
40,500
+32,000
+376% +$2.47M 0.03% 646
2020
Q3
$643K Buy
+8,500
New +$690K 0.01% 830
2019
Q4
Sell
-15
Closed -$1K 1155
2019
Q3
$1K Hold
15
﹤0.01% 1139
2019
Q2
$1K Buy
+15
New +$1.29K ﹤0.01% 1144

Other funds holding INGR

Royce & Associates's INGR Position: Q2 2022 in Review

Royce & Associates sold out of Ingredion (INGR) in Q2 2022, closing a stake of 50,000 shares — an estimated $4.36M sold.

Royce & Associates first reported a position in INGR in Q2 2019 and held it in 9 quarters. The position peaked at $4.74M in Q4 2021. 456 funds tracked by Wall St. Rank hold INGR as of Q2 2022.

  • Royce & Associates reported no remaining Ingredion position as of Q2 2022 after selling out during the quarter.
  • Royce & Associates sold 50,000 Ingredion shares in Q2 2022, an estimated $4.36M.
  • Royce & Associates first reported a position in Ingredion in Q2 2019 and held it in 9 quarters.
  • Royce & Associates's Ingredion position peaked at $4.74M in Q4 2021.
  • 456 funds tracked by Wall St. Rank held Ingredion as of Q2 2022.

Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.